Buruli ulcer

Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer)


Acknowledgements

With thanks to the following for their review and constructive comments on this document:

  • Dr John Buntine, Cornell Specialists’ Centre, Victoria, Australia
  • Dr Samuel Etuaful, St Martin’s Catholic Hospital, Agroyesum, Ghana
  • Dr Christian Johnson, Buruli Ulcer Control Programme, Cotonou, Benin
  • Professor Jacques Grosset, Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
  • Professor Francoise Portaels, Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium
  • Dr Mark Wansbrough-Jones, Division of Infectious Disease, St. George’s Hospital Medical School, London, United Kingdom
  • Stop TB Department, HIV/AIDS, Tuberculosis, Malaria, World Health Organization, Geneva, Switzerland
Share